Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Coxiella burnetii Probable chromosome-partitioning protein parB (parB) CSB-YP774391DXP
CSB-EP774391DXP
CSB-BP774391DXP
CSB-MP774391DXP
CSB-EP774391DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Peptidyl-tRNA hydrolase (pth) CSB-YP774392DXP
CSB-EP774392DXP
CSB-BP774392DXP
CSB-MP774392DXP
CSB-EP774392DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Uncharacterized protein CBU_1818 (CBU_1818), partial CSB-YP774393DXP1
CSB-EP774393DXP1
CSB-BP774393DXP1
CSB-MP774393DXP1
CSB-EP774393DXP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Probable GTP-binding protein EngB (engB) CSB-YP774394DXP
CSB-EP774394DXP
CSB-BP774394DXP
CSB-MP774394DXP
CSB-EP774394DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP774395DXP
CSB-EP774395DXP
CSB-BP774395DXP
CSB-MP774395DXP
CSB-EP774395DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Methionine--tRNA ligase (metG), partial CSB-YP774396DXP
CSB-EP774396DXP
CSB-BP774396DXP
CSB-MP774396DXP
CSB-EP774396DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Cell division protein FtsB (ftsB), partial CSB-YP774397DXP
CSB-EP774397DXP
CSB-BP774397DXP
CSB-MP774397DXP
CSB-EP774397DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Probable transcriptional regulatory protein CBU_1566 (CBU_1566) CSB-YP774398DXP
CSB-EP774398DXP
CSB-BP774398DXP
CSB-MP774398DXP
CSB-EP774398DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (gpmI), partial CSB-YP774399DXP
CSB-EP774399DXP
CSB-BP774399DXP
CSB-MP774399DXP
CSB-EP774399DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Pyridoxine 5'-phosphate synthase (pdxJ) CSB-YP774400DXP
CSB-EP774400DXP
CSB-BP774400DXP
CSB-MP774400DXP
CSB-EP774400DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii NADH-quinone oxidoreductase subunit A (nuoA), partial CSB-YP774401DXP1
CSB-EP774401DXP1
CSB-BP774401DXP1
CSB-MP774401DXP1
CSB-EP774401DXP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii NADH-quinone oxidoreductase subunit K (nuoK), partial CSB-YP774402DXP1
CSB-EP774402DXP1
CSB-BP774402DXP1
CSB-MP774402DXP1
CSB-EP774402DXP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Transcriptional repressor NrdR (nrdR) CSB-YP774403DXP
CSB-EP774403DXP
CSB-BP774403DXP
CSB-MP774403DXP
CSB-EP774403DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP774404DXP
CSB-EP774404DXP
CSB-BP774404DXP
CSB-MP774404DXP
CSB-EP774404DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii 50S ribosomal protein L35 (rpmI) CSB-YP774405DXP
CSB-EP774405DXP
CSB-BP774405DXP
CSB-MP774405DXP
CSB-EP774405DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP774406DXP
CSB-EP774406DXP
CSB-BP774406DXP
CSB-MP774406DXP
CSB-EP774406DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Dihydrodipicolinate synthase (dapA) CSB-YP774407DXP
CSB-EP774407DXP
CSB-BP774407DXP
CSB-MP774407DXP
CSB-EP774407DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Probable tRNA sulfurtransferase (thiI) CSB-YP774408DXP
CSB-EP774408DXP
CSB-BP774408DXP
CSB-MP774408DXP
CSB-EP774408DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Segregation and condensation protein A (scpA) CSB-YP774409DXP
CSB-EP774409DXP
CSB-BP774409DXP
CSB-MP774409DXP
CSB-EP774409DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Biotin synthase (bioB) CSB-YP774410DXP
CSB-EP774410DXP
CSB-BP774410DXP
CSB-MP774410DXP
CSB-EP774410DXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>